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mechanism of toxicity both involve membrane interactions. We have studied Alzheimer’s disease related amyloid beta peptide
(Ab). Recombinant Ab(M1–40) and Ab(M1–42) produced in Escherichia coli, allows us to carry out large scale kinetics assays
with good statistics. The amyloid formation process is followed in means of thioﬂavin T ﬂuorescence at relatively low (down to
380 nM) peptide concentration approaching the physiological range. The lipid membranes are introduced in the system as large
and small unilamellar vesicles. The aggregation lagtime increases in the presence of lipid vesicles for all situations investigated
and the phase behavior of the membrane in the vesicles has a large effect on the aggregation kinetics. By comparing vesicles
with different membrane phase behavior we see that the solid gel phase dipalmitoylphosphatidylcholine bilayers cause the
largest retardation of Ab ﬁbril formation. The membrane-induced retardation reaches saturation and is present when the vesicles
are added during the lag time up to the nucleation point. No signiﬁcant difference is detected in lag time when increasing amount
of negative charge is incorporated into the membrane.INTRODUCTIONTo date, ~30 proteins are known to form amyloid fibrils and
deposits in humans. Depending on protein and location this
causes different diseases. For the majority of the diseases, the
detailed biochemical mechanisms are not known, but lipid
membranes are gaining interest as a potentially important
factor in disease propagation. In the amyloid plaques associ-
ated with several amyloidogenic diseases, tightly associated
lipids have been identified, especially lipids associated with
so-called lipid rafts (1). The amyloid fibril formation
proceeds via transient oligomers that eventually go on to
more stable fibrils and the intermediate small oligomers,
have been found to be the toxic species rather than the mono-
mers or fully formed amyloid fibrils (2). It is not known if
this is due to specific interactions caused by the structure
or size of the oligomers, or if it is because the oligomers
are potent intermediates in the amyloid formation process.
The molecular details behind the involvement of membrane
in the amyloid formation mechanism are much debated. In
one model, the lipid membrane produces a catalytic surface
for amyloid formation (3). In another model, oligomers form
ion channels in the membrane leading to apoptosis (4).
Further models propose that amyloid formation changes
the fluidity of the membrane or that the membrane is disrup-
ted in the amyloid formation process (5–7).
The amyloid beta peptide (Ab) (Fig. 1 C) associated with
Alzheimer’s disease is produced from the amyloid precursor
protein (APP) by specific proteases. The C-terminus of the
peptide originates from the membrane incorporated part of
APP and this gives Ab an amphiphilic character. The cleavedSubmitted July 10, 2009, and accepted for publication January 27, 2010.
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0006-3495/10/05/2206/9 $2.00peptide can vary in length but Ab(1–40) and Ab(1–42) are
the most common products. Due to the extension in the
more hydrophobic C terminus, Ab(1–42) is more aggrega-
tion prone than Ab(1–40) and an increased level of
Ab(1–42) relative to Ab(1–40) is a risk factor for developing
Alzheimer’s disease. Aggregation of Ab has been associated
to, e.g., membrane barrier disruption and lipid regulation in
cells, and it has been proposed that variations in lipid compo-
sition, and in particular the presence of raft domains, can
affect the amyloid toxicity in cells (8,9).
A large number of model studies of Ab–membrane inter-
actions have been carried out with the membrane as a depos-
ited bilayer, a monolayer, or in the form of vesicles dispersed
in solution. Although the results are contradictory in some
respects, well-founded conclusions are strong interactions
between the Ab peptide and lipid membranes and that
membranes can be permeabilized by the Ab peptide during
the amyloid formation process. The composition of the lipid
membrane is considered important for membrane interac-
tions with Ab. In particular, the liquid ordered domains
known as lipid rafts have been related to amyloid formation.
Common components of lipid rafts such as cholesterol,
sphingomyelin, and gangliosides have all been reported as
having increased interactions with Ab peptide (10–12) and
raft lipid components have been found tightly associated
with amyloid plaques extracted from patients (1).
Lipid membranes have been reported to both accelerate
and retard amyloid formation (reviewed in Murphy (13)).
This may indicate that the precise conditions of the measure-
ments will make one or the other effect dominating;
however, high resolution kinetic data with good statistics
of amyloid formation in the presence of lipid membranes
have been lacking. In most cases, only a few or only
endpoint measurements are reported but there are exceptions,doi: 10.1016/j.bpj.2010.01.063
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FIGURE 1 (A) Schematic illustration of the bilayer phases in the vesicles
used in this study. By combining DOPC, DPPC, and cholesterol, three
different phases were achieved with different degrees of translational diffu-
sion and acyl chain order. (B) Chemical structure of used lipids. (C) Amino
acid sequence of Ab(M1–42) with hydrophobic residues in bold. Residues
that are negatively () or positively (þ) charged or titrating (t) at neutral
pH are indicated under the sequence. The last two residues (IA) are missing
in Ab(M1–40).
Membrane Effects on Ab Fibril Formation 2207e.g., Sabate et al. (14) show with good reproducibility that
there is a small delay in Ab(1–40) amyloid formation on
soy bean phosphatidylcholine (PC) addition. The Ab aggre-
gation kinetics have been assumed to be stochastic on a
macroscopic level (15), but recent developments show that
this is not the case and Ab aggregation kinetics are concen-
tration dependent in a highly reproducible manner (16).
These findings rely on the use of recombinant Ab expressed
in large scale in Escherichia coli (17) to overcome the high
cost of synthetic peptide and allow for collection of enough
data to obtain good statistics and refinement of the experi-
mental setup. The collection from size exclusion chromatog-
raphy of pure monomeric peptide in the degassed experi-
mental buffer with no additives is especially essential.
This study addresses the effect of phospholipid mem-
branes on the aggregation kinetics of Ab under conditions
approaching the in vivo situation in terms of low Ab concen-
tration, low Ab to membrane/surface ratio, and absence of
cosolvents. We have studied the kinetics of Ab aggregation
in the absence and presence of model membranes in the form
of large and small unilamellar vesicles of defined composi-
tion. Vesicles with different compositions of phospholipids
and cholesterol were designed to elucidate different proper-
ties of lipid membranes such as phase behavior and charge.Aggregation of recombinant peptides Ab(M1–40) and
Ab(M1–42) were monitored using thioflavin T (ThT) fluo-
rescence. To study the role of membrane phase behavior
(liquid disordered versus liquid ordered versus gel phase),
we have compared the effect of vesicles containing phospho-
lipids with the same PC headgroup but different acyl chains,
with and without cholesterol. To study the role of membrane
charge we have compared the effect of vesicles containing
anionic phosphatidylserine (PS), and we relate the result to
interaction studies with monolayer technique. Our data
show that biological membranes may retard Ab aggregation
in a manner dependent on membrane phase behavior but
independent of membrane charge.MATERIALS AND METHODS
Vesicle preparation
Dioleoyl-phosphatidylcholine (DOPC), dioleoyl-phosphatidylserine (DOPS),
cholesterol were obtained from Avanti Polar Lipids (Alabaster, AL)
and dipalmitoyl-phosphatidylcholine (DPPC) was obtained from Larodan
(Malmo¨, Sweden) (Fig. 1 B). Unilamellar vesicles (200 nm) were prepared
from 5 mM stock solutions of phospholipids and cholesterol in chloroform/
methanol 9:1 v/v. Thin lipid films were deposited onto glass tubes under
a slow flow of nitrogen and dried in vacuum over night at 50C. The films
were hydrated with 20 mM Tris/HCl pH 7.4 with 0.2 mM EDTA and 0.02%
NaN3, unless otherwise stated, to a final concentration of 5 mM lipid. Large
unilamellar vesicles (200 nm) were formed by 10 freeze-thaw cycles and 10
extrusions through a 200 nm cellulose filter. pH was readjusted before extru-
sion, keeping the ionic strength constant, with 20 mM Tris 0.2 mM EDTA
0.02% NaN3 to a final pH of 7.4. Sonicated small unilamellar vesicles were
prepared by microtip sonication at 40% duty cycle for 20 min followed by
centrifugation for 3 min at 13,000  g.
Phospholipid concentrations were determined by phosphate analysis
according to Rouser et al. (18). Dried samples were digested with 0.65 mL
70% perchloric acid at 180C for 20 min and when cool, 3.3 mL ddH2O,
0.5 mL 25 g/L ammonium molybdate and 0.5 mL 100 g/L ascorbic acid
were added. After heating for 5 min at 100C, absorbance was read at
800 nm. A solution of KH2PO4 was used as standard in additions corre-
sponding to 0–5 mg phosphor in each tube.
Ab peptide
The peptides studied in this work, Ab(M1–40) and Ab(M1–42), comprise
residues 671–711 and 671–713, respectively, of human APP (Fig. 1 C).
The peptides were expressed in E. coli (strain BL21 star pLysS De3) from
a synthetic gene with E. coli optimized codons and purified from inclusion
bodies by ion exchange and size exclusion (17). Synthetic peptide Ab(1–40)
(R95% pure) was purchased from Genscript (Piscataway, NJ). Both
recombinant and synthetic peptide were further purified by gel filtration in
the experimental buffer for the kinetic experiments to isolate monomer
just before initiating the aggregation kinetics measurements (see below).
Kinetics experiments
Monomeric Ab was collected from a 1  30 cm Superdex 75 column in
20 mM Tris/HCl, pH 7.4, 0.2 mM EDTA, 0.02% NaN3 directly into
a low bind Eppendorf tube on ice. The Ab concentration was determined
by integration of the absorbance peak in the FPLC chromatogram using
an extinction coefficient of 1440 cm1 M1 at 280 nm. The monomer stock
was then mixed with filtered buffer (20 mM Tris/HCl, pH 7.4, 0.2 mM
EDTA, 0.02% NaN3), ThT and vesicles to desired concentrations in
low bind Eppendorf tubes on ice. One stock solution was made for eachBiophysical Journal 98(10) 2206–2214
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on a 96-well low bind half area plate (Corning 3881) on ice. Each well con-
tained 100 mL solution with a ThT concentration of 20 mM. By using the
maximum volume in a half area plate the air surface/volume ratio is mini-
mized, which is important because Ab is surface active. The plate was sealed
with a plastic film, not in contact with the solution, to eliminate evaporation.
The experiment was started by putting the plate in a plate reader, Fluostar
Omega (BMG Labtech, Offenburg, Germany), thermostated at 37C, and
starting shaking at 100 rpm. ThT fluorescence was measured from the
bottom of the plate every fifth minute through excitation and emission filters
of 440 and 480 nm, respectively, with continuous orbital shaking between
measurements. Vesicles incubated with ThT in absence of peptide showed
no change in intensity over time and no change in vesicle size could be
detected from dynamic light scattering when incubating DOPC vesicles
for 10 h at 37C and 100 rpm.
DSC measurements
DSC experiments were carried out using a vp DSC from MicroCal (North-
ampton, MA) with a cell volume of 0.5072 mL. Temperature was changed
by 1C/min during the measurements.
Surface balance
DPPC or 1,2-dimyristoyl-sn-glycero-3-phospho-L-serine monolayer was
applied on 20 mL 20 mM Tris, pH 7.4, 0.02% NaN3, 0.2 mM EDTA
from 10 mL 1 mM lipid in chloroform/methanol 9:1 and was left for
10 min to evaporate the organic solvent. The monolayer was then com-
pressed to 30 mN/m before relaxed to experimental surface pressure. Injec-
tion of Ab(M1–40) or buffer was made by injecting 2 mL under one barrier
and withdrawing 2 mL from the outside of the other barrier.
Dynamic light scattering
Dynamic light scattering measurements were carried out using a Zetasizer
Nano ZS (Malvern Instruments, Malvern, UK). Dynamic light scattering
experiments were carried out on vesicle suspensions at 22C.
Circular dichroism spectroscopy
Circular dichroism (CD) spectra were recorded in a 10-mm quartz cuvette
between 300 and 190 nm using a Jasco J-815 CD spectrometer (Jasco,
Easton, MD) at 1 nm bandwidth, 0.1 nm interval, and 1 s response time.
Ab(M1–40) monomer was isolated on a Superdex 75 column in 20 mM
PO4, 0.05 mM EDTA buffer. After 3 dilution with ddH2O, one spectrum
was recorded for 10 mM peptide. After addition of DOPC vesicles, extruded
through a 100 nm filter, 17 spectra were recorded with 5-min intervals at
~0.2 mM DOPC and 8.6 mM peptide.RESULTS
On binding to the cross-b structure in amyloid fibrils and
oligomers, the fluorescence from the organic dye ThT expe-
riences a red shift and gives an increased signal at 482 nm
when excited at 442 nm. This feature allows for the use of
ThT as a reporter on the propagation of amyloid fibril forma-
tion. The specificity and mechanism of ThT binding in the
pathway of amyloid formation is still debated but in designed
proteins with cross-b structures, ThT has been observed to
bind cross-b ladders as small as four to five strands (19), cor-
responding to tetramer to pentamer of Ab peptide. The ThT
fluorescence trace from amyloid formation is characterized
by a sigmoidal curve shape. During the initial lag phase, olig-Biophysical Journal 98(10) 2206–2214omers are built up to the critical size detectable by ThT
and during the elongation phase the fluorescence intensity
increases rapidly as fibrils elongate. After the elongation
phase, the fluorescence intensity levels off to a plateau value
when the monomer concentration approaches its equilibrium
value in the presence of the formed fibrils. To allow good
statistics in the kinetics studies, the amyloid formation was
followed for multiple 100-mL replicates of each solution,
in wells of a 96-well low bind half area plate. Pure monomer
was collected on ice in the degassed experimental buffer
from size exclusion chromatography just before the start of
the experiment. Thus the experiment is carried out in a
pure buffer system with no cosolvents. After dilution and
addition of vesicle solutions to desired concentrations, the
experiment was initiated by placing the sealed plate in a plate
reader thermostated at 37C. With 100 rpm shaking, the ThT
fluorescence was measured from all wells every fifth minute.
The most common type of phospholipids in human cell
membranes, PC, was chosen as the primary lipid component
of the model membranes. The lipid was added as large
unilamellar vesicles prepared by extrusion through a 200 nm
filter or as small unilamellar vesicles prepared by sonication,
~50 nm diameter as measured from dynamic light scattering.
Depending on the length and degree of saturation of the
phospholipid acyl chains (Fig. 1 B) and the amount of
cholesterol dissolved in the membrane, the PC bilayer adopts
different phase behavior as illustrated in Fig. 1 A. Fig. 2
shows kinetic traces from ThT fluorescence, reporting on
amyloid formation, for Ab(M1–40) and the more hydro-
phobic Ab(M1–42) in the absence and presence of large
unilamellar vesicles composed of DOPC. The presence of
the vesicles cause a delay in the amyloid formation for
both peptides investigated, indicating interference with the
aggregation process. Incubation of ThT and vesicles in
absence of peptide showed no change in signal over time
(data not shown).
To investigate the influence of lipid phase behavior on the
aggregation kinetics, the aggregation of Ab(M1–40) was
studied in the presence of DOPC vesicles as well as DPPC
vesicles with and without cholesterol incorporation. DOPC
has a melting temperature of ~20C and at physiological
temperature it forms liquid disordered lamellar phase,
La(d), with high lateral diffusion and disordered acyl chains.
DPPC, has a melting temperature of 42C and forms a solid
lamellar gel phase, Lb0, at physiological temperature. The gel
phase is characterized by low lateral diffusion and highly
ordered acyl chains. Consequently, the gel phase has a tighter
lipid packing with an average area per headgroup of 46 A˚2
for DPPC in Lb0 compared to 68 A˚
2 for DOPC in La(d)
(20). When >20% cholesterol is introduced into the DPPC
Lb0 membrane, a liquid ordered bilayer phase, La(o), is
formed (21), which has high order in the acyl chains but
also a high lateral diffusion much closer to La(d) than Lb0
(22,23). In contrast to the DPPC case, the introduction of
cholesterol into the DOPC La(d) bilayer increases the acyl
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FIGURE 3 ThT fluorescence kinetic traces for 6.0 mM Ab(M1–40) in the
presence of (A) DOPC or (B) DPPC in small unilamellar vesicles with (solid
lines) or without (dashed lines) membrane-incorporated cholesterol in
20 mM Tris/HCl, pH 7.4, 0.2 mM EDTA, 0.02% NaN3 with 20 mM ThT.
Cholesterol was added at a ratio of 2:1 PC/cholesterol and the total lipid
concentration is in all cases 1.9 mM. Each line represents one replicate in
a separate well.
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FIGURE 4 Lagtime dependence on DPPC concentration. 6.8 mM
Ab(M1–40) was incubated with different concentrations of DPPC present
as large unilamellar vesicles in 20 mM Tris/HCl, pH 7.4, 0.2 mM EDTA,
0.02% NaN3 with 20 mM ThT. The half-time of completion, t0.5, is defined
as time at 50% of maximum intensity and the error bars represent the
standard deviation from five wells.
Membrane Effects on Ab Fibril Formation 2209chain order, with just a small change in the translational
diffusion, toward La(o) (23).
We noted that the extruded Lb0 DPPC vesicles sometimes
were already significantly smaller than 200 nm after the
freeze thaw cycles and therefore much smaller than the
La(d) DOPC vesicles prepared according to the same
protocol. To enable comparisons between systems with vesi-
cles of similar size, we therefore used sonicated small unila-
mellar vesicles in the phase comparison. Fig. 3 shows that
the lag time for the amyloid formation is considerably shorter
when aggregation takes place in the presence of liquid
ordered DPPC-cholesterol vesicles compared to solid gel
phase DPPC vesicles. For the pure DOPC vesicles only a
minor delay of the amyloid formation is observed, and
introduction of cholesterol into the DOPC membrane only
has a small accelerating effect. Because the headgroups of
DOPC and DPPC are identical, this observed difference
between the Lb0 DPPC vesicles and the La(d) DOPC vesicles
most likely comes from the difference in phase behavior. The
traces from the peptide in absence of lipids are not included
in Fig. 3 for clarity but overlapped with the curves for DPPC/
cholesterol.
The dependence of aggregation kinetics on the ratio
between the vesicle and peptide concentration may contain
further information about the mechanism of the interference
in the amyloid formation process caused by the lipid vesi-
cles. Fig. 4 shows how the time of half completion of the
amyloid formation of Ab(M1–40) varies with the concentra-tion of DPPC present as large unilamellar vesicles. Although
the concentration dependence has the appearance of a
binding curve, it could not be fitted with any meaningful
binding equation because both stoichiometry and binding
affinity are unknown and interdependent parameters in a
binding equation. However, the system seems to reach satu-
ration around a DPPC/Ab(M1–40) ratio of 1:15-30.
To evaluate at which stage in the amyloid formation
process the vesicles interfere, an experiment was started
with multiple identical replicates of 50 mL 12 mM
Ab(M1–40) per well. At each time point (ranging fromBiophysical Journal 98(10) 2206–2214
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FIGURE 6 Lagtime dependence on membrane charge. Ab(M1–40)
(6.7 mM) was incubated with large unilamellar vesicles of different
DOPS/DOPC ratios in 20 mM Tris/HCl, pH 7.4, 0.2 mM EDTA, 0.02%
NaN3 with 20 mM ThT. The total phospholipid concentration was kept
constant at 1.2 mM. Each point represents the mean incubation time until
50% of maximum intensity is reached5 standard deviation from five wells.
Dashed lines represent standard deviation error limits for five samples of
peptide in absence of lipids.
2210 Hellstrand et al.0 to 254 min), two wells were complemented with 50 mL 2.7
mM DPPC and two wells were complemented with 50 mL
buffer (Fig. 5). When the vesicles were added during the first
hour of the experiment, the resulting lag time was prolonged
from 2 to 9 h. When the addition was made later than 1 h
after starting the experiment, the delay in lag time induced
by the addition of vesicles diminished and after 2 h nearly
no delay in lag time was observed on vesicle addition.
When the vesicles were added in the elongation phase (steep
part of the curve), the increase in ThT fluorescence was
continued as in the undisturbed case. Any change in elonga-
tion rate on vesicle addition is hard to separate from the
change in intensity caused by dilution of the peptide and
light scattering from the vesicles.
Amyloid formation of Ab(M1–40) was finally investi-
gated in the presence of vesicles composed of DOPS and
DOPC at varying molar ratios (Fig. 6). DOPS is an anionic
phospholipid, and the mixed DOPC/DOPS vesicles form a
La(d) phase. Fig. 6 shows that aggregation lag time is
approximately the same for all DOPS/DOPC compositions
investigated, and thus no significant effect of increasing
the membrane negative charge can be seen. To further
analyze the electrostatic component of the Ab peptide-0 1 2 3
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FIGURE 5 Addition of DPPC vesicles at different time points during the
amyloid formation process. The experiment was started with 50 mL 12 mM
Ab(M1–40) in 20 mM Tris/HCl, pH 7.4, 0.2 mM EDTA, 0.02% NaN3 with
20 mMThT. At different time points, 50 mL 2.7 mMDPPC large unilamellar
vesicles or 50 mL buffer was added. (A) ThT fluorescence versus time.
Vertical lines indicate the time of vesicle or buffer addition as also given
as numbers in each panel. Solid lines represent data from wells to which
vesicles were added and dashed lines data from wells to which buffer was
added. (B) Lag time as a function of time of vesicle (solid circles) or buffer
(open circles) addition. Each point represents an average of two replica and
the lag time is defined as the time at which 10% of the maximum fluores-
cence is reached. Dashed lines indicate the lag time in the absence of
vesicles.
Biophysical Journal 98(10) 2206–2214membrane interaction, the influence of salt concentration
was studied. The aggregation kinetics for both Ab(M1–40)
and Ab(M1–42) are found to be strongly dependent on salt
concentration, with a shorter lag time at higher salt concen-
tration, and the lag time in the presence of DOPC vesicles
decreased with increasing ionic strength. However, a longer
lag time is observed in the presence of DOPC vesicles
compared to Ab alone at all NaCl concentrations studied
ranging from 0 to 160 mM (in 20 mM Tris/HCl pH 7.4,
0.2 mM EDTA, 0.02% NaN3 with 20 mM ThT; data not
shown).
The recombinant Ab peptides used in this study have
methionine preceding position 1 (that is an aspartate),
whereas synthetic Ab peptides start at position 1 like the
majority of in vivo generated Ab. Control experiments with
monomeric synthetic peptide Ab(1–40) purified from size
exclusion were therefore carried out. A higher concentration
of synthetic peptide was needed compared to recombinant
Ab(M1–40) peptide to produce equal lag times. This could
be explained by the methods of preparation. The recombinant
Ab(M1–40) has no variation in length whereas the synthetic
Ab(1–40) preparation may be less homogeneous, containing
shorter fragments affecting the kinetics. The aggregation
kinetics were however slowed down for both synthetic and
recombinant peptide when adding DOPC, DPPC, or
DOPC/DOPS large unilamellar vesicles.
So far, the presented data all concern the influence of lipid
vesicles on the aggregation kinetics. Although the relation
between interference caused by the vesicles and peptide-
vesicles association is not considered trivial, we believe it
makes sense to relate the kinetic data to a study of peptide
adsorption to lipid membranes. We carried out monolayer
experiments to elucidate if there is any difference in
membrane adsorption of monomeric Ab peptide depending
Membrane Effects on Ab Fibril Formation 2211on lipid charge and lipid acyl-chain packing. Fig. 7 shows
the change in surface pressure (DP) when monomeric
Ab(M1–40) was injected under PC and PS monolayers at
6 mN/m and 25 mN/m initial surface pressure. At the low
initial surface pressure, the monolayer is in a liquid expanded
(LE) phase, and at the high initial surface pressure, the
monolayer is in a liquid condensed (LC) phase. The LE
monolayer can be considered a fluid phase where the hydro-
carbon chains have a high conformational disorder, whereas
the LC phase have small cross-sectional areas per lipid and
highly ordered hydrocarbon chains. Comparisons of the
chain order and the headgroup areas with those seen in
bulk lamellar phases suggest that the molecular properties
of the LE and LC phases are similar to those found in the
liquid crystalline and gel bilayers, respectively (24). From
the data in Fig. 7 we conclude that surface pressure increases
over time for both types of lipids both in the LE and the LC
phases. At both high and low surface pressure the peptide
adsorption to the monolayer is slightly faster for PC head-
groups compared to PS. A deeper analysis of these data is
complicated by the fact that the Ab peptide is highly surface
active in itself (25), and it is not evident what are that the
driving forces for peptide adsorption to the monolayer.
However, the data clearly show that there is no significant
difference in peptide adsorption as measured as the total
increase in DP between the zwitterionic and anionic mono-
layers. Monomeric Ab peptide was used and we do not0
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FIGURE 7 Langmuir monolayer experiment. 2 ml 30 mM Ab(M1–40)
was injected under a monolayer of DPPC or 2,3-dimercapto-1-propanesul-
fonic acid on a subphase of 20 mL 20 mM Tris/HCl, pH 7.4, 0.2 mM
EDTA, 0.02% NaN3. (A) Liquid expanded phase (p0 ¼ 6 mN/m) as a
model for liquid disordered bilayer phase. (B) Liquid condensed phase
(p0 ¼ 25 mN/m) as a model for gel bilayer phase. The small pressure
drop during injection due to mechanical disturbance is corrected for and
Dp is thus defined as pressure increase after injection.predict aggregation in the still bulk solution within the period
of the experiment. We are therefore not able to draw any
conclusion on association of oligomeric or fibrillar aggre-
gates to the lipid monolayer.
We also measured the CD spectra of Ab(M1–40) but saw
no change in the presence of DOPC-vesicles. No helix struc-
ture could be detected in the absence or presence of lipids
(data not shown).DISCUSSION
We believe the present data shows clearly that lipid vesicles
can interfere with the aggregation of the Ab peptide, and that
this interference can be modulated by varying the properties
of the lipid system. The lipid vesicles provide an interface
that can potentially act as a catalytic or inhibiting surface,
and can thereby influence the aggregation kinetics in similar
manner as has been shown for e.g., nanoparticles (26,27).
Moreover, the lipid vesicles are dynamic entities and the
self-assembled structure can be altered due to the lipid-
peptide interactions. In all experiments carried out in this
study, the presence of unilamellar vesicles either retards or
has no effect on Ab amyloid formation. Ab(M1–42) is intrin-
sically more aggregation-prone than Ab(M1–40) and
Ab(M1–42) was therefore studied at lower peptide concen-
tration than Ab(M1–40). However, the addition of lipid
vesicles produces qualitatively the same effects on the aggre-
gation kinetics for both peptides, and in no case do we see an
acceleration of fibril formation due to the membranes. Thus,
in the pure buffer system used in this study, there is no indi-
cation that the membrane acts as a general nucleating surface
for amyloid formation. Rather, the lipid membrane systems
studied here interact with the peptide monomers or oligo-
mers in a way that hinders the kinetics of the process under
the conditions of this study (4.8–12 mM Ab(M1–40) or
0.38–0.59 mM Ab(M1–42) with 0.85–2.7 mM phospholipid
in 20 mM Tris/HCl, 0.2 mM EDTA, 0.02% NaN3, pH 7.4
with no cosolvents or other additives such as hexafluoroiso-
propanol or DMSO). This does not exclude the possibility
that lipid membranes have accelerating effects at other
combinations of peptide and lipid concentration, or in the
presence of other solution components. A notable difference
between this and other studies of the effect of membranes on
Ab aggregation is that we use lower peptide concentration.
The low peptide concentrations used here (380 nM–12 mM)
approaches typical physiological concentrations (1.5 nM in
healthy individuals and higher in patients (28,29)) and in a
pure buffer system with no additives, such low concentra-
tions are needed to obtain kinetic data with a distinct lag
phase. The low peptide concentration also assures for a
low peptide to lipid ratio as is the case in vivo. Other studies
have reported distinct effects of agents (surfactants or nano-
particles) on aggregation kinetics depending on the ratio
between protein and agent with an acceleration of aggrega-
tion in the regime of high protein/agent ratio and retardationBiophysical Journal 98(10) 2206–2214
2212 Hellstrand et al.in the low protein/agent regime (30,31). This further under-
scores the importance of the experimental conditions used.
Thus, with low Ab concentration, low Ab/vesicle ratio and
solutions free from cosolvents, we find either a retardation
or no effect depending on the membrane composition.
The ThT assay used is primary in the respect that it allows
us to directly monitor the propagation of amyloid formation
in real time, but the effect from lipid bilayers is seen as a
secondary kinetic effect. We believe the present data are
consistent with adsorption (association) of Ab peptide to
the lipid bilayers, and provides quantitative measures of
the aggregation kinetics at given conditions for the lipid/
peptide ratio in solution. However, the data cannot be quan-
titatively correlated to the amount of peptide associated with
the vesicles, and should therefore be looked on in relation to
the extensive literature on this matter (3,10,27,28).
The model systems are chosen so that the phase behavior
is varied by using lipids with different acyl-chains or by
introducing cholesterol, whereas the lipid headgroup and
the PC concentrations are the same. The observation that
the delay in aggregation in the presence of DPPC vesicles
is greatly reduced when the vesicles are instead in liquid
ordered or liquid disordered state either by cholesterol incor-
poration or exchange of DPPC for DOPC, imply that the
aggregation kinetics is in some way related to the lipid phase
behavior.
Two scenarios for how lipid membranes can affect the
aggregation kinetics are consistent with the prolonged lag-
time: i), the amyloid formation can take place in bulk with
part of the peptide partitioning to the membrane, causing
an effectively lower bulk concentration and thus slower
aggregation (16); or ii), the amyloid formation can take place
at the membrane surface with the peptide membrane associ-
ated. The observed differences in aggregation kinetics may
arise from higher partitioning of the peptide to gel state bila-
yers compared to the liquid crystalline bilayers, which would
then support the first scenario described above. Indeed, high
Ab binding specificity for gel phase lipid bilayers finds some
support in the literature (32,33). Still, this mechanism alone
cannot explain that the addition of vesicles of DOPC or
DPPC with cholesterol causes only very minor delays in
the aggregation kinetics, as there are accumulating evidences
pointing to higher affinity of Ab for bilayers and monolayers
that contain cholesterol (10,11,34,35).
The aggregation kinetics may be influenced by the mode
of Ab peptide association with the membrane, although it
is not trivial to predict how a specific interaction will affect
the aggregation process. The peptide may be located in the
bilayer interfacial headgroup region, or it may penetrate
into the hydrophobic layer of the bilayer. Several report
show that Ab fragments can bury in the acyl-chain regions
in zwitterionic and anionic phospholipid La(d) bilayers
(5,34,36,37), whereas less or no penetration into the hydro-
phobic core of the bilayer has been detected at high choles-
terol concentrations (La(o) bilayers) or for gel phase bilayers.Biophysical Journal 98(10) 2206–2214Corresponding results have been obtained for expanded and
condensed phospholipid monolayers (37,38). It is also
possible that there is accumulation of peptides in domain
boundaries or defects, as reported for line-active proteins
(39,40). It is well-known that small unilamellar gel phase
vesicles can exhibit faceted structure with areas of planar
bilayer structures (41,42). In the edges between the facets,
the bilayer is highly curved and the packing of the acyl-chain
is naturally different from the planar areas of the bilayer. It is
possible that the peptides accumulate in such areas with
packing defects.
For a diffusion-controlled process, such as the aggrega-
tion, the influence of membrane association on the diffusion
might influence the aggregation. This is particularly relevant
if there is a tight membrane association, where the peptide
spends a large fraction of time in a membrane associated
state. The different model membrane systems used in this
study show clearly different lateral diffusion characteristics
(23). This might provide an explanation for the results
obtained for the PC systems showing a large delay in aggre-
gation for the solid gel phase vesicles compared to the liquid
crystalline vesicles, and it is in agreement with the second
scenario of membrane associated aggregation suggested
above. Assuming equal partitioning of Ab to the PC mem-
brane regardless of phase behavior, Ab would be consider-
ably more hindered in the translational diffusion in the
membrane surface in the DPPC solid bilayer compared to
the liquid crystalline bilayer. In such case, the half time,
t0.5, seen at high DPPC concentration in Fig. 4 would repre-
sent t0.5 when all peptide is membrane bound and hindered by
the low translational diffusion in the DPPC solid gel phase.
The concentration dependence of DPPC vesicles on t0.5
of Ab(M1–40) aggregation reaches a plateau value at a
stoichiometry of 15–30 lipids/peptide (Fig. 4). Because the
membrane is a double layer and the majority of the vesicles
are unilamellar, this corresponds to a presented phospholipid
to peptide ratio of 1:7.5–15. The t0.5 value at the plateau may
represent membrane bound peptide that is diffusion limited
by the solid gel phase DPPC. Given a DPPC headgroup
area in the gel phase of 46 A˚2 (20), a stoichiometry of
15–30 corresponds to 345–690 A˚2 or 19  19 to 26  26 A˚
membrane surface area presented per peptide. These num-
bers should be considered as maximum surface area per
peptide, in case not all vesicles are unilamellar, and imply
a rather dense incorporation of Ab in the membrane. If
globular, the Ab peptide would have a diameter of ~20 A˚,
whereas a cross section with smaller or larger diameter
may be achieved for an extended peptide depending on
orientation.
An important aspect of physiological membranes is their
negative charge, and interactions of Ab with anionic phos-
pholipids are somewhat controversial (12). We observe
approximately the same lengthening of the lag phase for
Ab fibrillation regardless of the DOPS/DOPC ratio in the
range 0:1–2:1 (Fig. 6).
Membrane Effects on Ab Fibril Formation 2213The Ab peptide is highly surface active and it unspecifi-
cally adsorbs to many surfaces. This complicates the design
of adsorption experiments. Comparative experiments be-
tween supported bilayers are difficult to evaluate as the
surface coverage for bilayers of different composition is
unknown and the peptide often binds to the underlying
supporting material. Lipid monolayers have the benefit of
always having 100% coverage and were therefore chosen
for interaction studies to compare binding to monolayers of
different composition and surface pressure. The monolayer
experiments show no significant difference in the adsorption
of monomeric Ab(M1–40) to PS and PC monolayers at the
air-water interface.
At pH 7.4, Ab has a net charge of 3 (see Fig. 1 C),
whereas PC is zwitterionic and PS has a net charge of 1.
It is somewhat surprising that neutral or highly negatively
charged large unilamellar vesicles affect the rate of amyloid
formation equally. This suggests that the electrostatic repul-
sion between Ab and the negatively charged phospholipid
headgroups is overcome by other highly favorable interac-
tions, e.g., between the hydrophobic tail of Ab and the
interior of the bilayer. The aggregation kinetics for both
Ab(M1–40) and Ab(M1–42) were found to be strongly
dependent on salt concentration, with a shorter lag time
observed at higher salt in agreement with earlier studies
(43). This implies that the net negative charge (3) of Ab
counteracts aggregation and that the electrostatic repulsion
between peptides is screened by salt. A reduced inhibition
of aggregation due to reduced electrostatic repulsion may
also explain the faster aggregation of familial Ab mutants
with 1 or 2 net negative charge (44). The lag time in the
presence of DOPC vesicles decreased with increasing ionic
strength but was always prolonged compared to the peptide
in absence of vesicles. This shows that the retarding effect
of DOPC membranes on Ab fibril formation persists
at physiological salt, and that the screening of inter-Ab
repulsion by salt may speed up fibril formation also for the
membrane associated peptide. Based on this, it seems
unlikely that the interaction between the peptide and the
membrane should be mainly electrostatic in its nature. We
believe, however, that any quantification here is impossible
because there is no trivial function describing the relation
between the peptide-membrane interaction and the lag time.
No clear trend could be detected in the elongation rates.
This indicates that the mechanism behind the increased lag
time must originate in interferences taking place during the
build up of small oligomers from monomers. Once nucle-
ated, the aggregation process proceeds with the same rate
in the absence and presence of membranes.CONCLUSION
Phospholipid membranes delay the onset of Ab fibril forma-
tion. By comparing vesicles with different membrane phase
behavior we conclude that the solid gel phase DPPC retardsthe fibril formation. The most possible explanation for this
retardation is due to bilayer defects in faceted vesicles and
low lateral diffusion in the bilayer. The retardation of Ab
fibril formation kinetics in the presence of vesicles reaches
saturation and is present when the vesicles are added during
the lag time up to the nucleation point. Both free and
membrane-bound peptide is screened by salt leading to a
shortening of the lag phase. Neutral and negatively charged
PC and PS model membranes retard fibril formation to the
same extent implying that the electrostatic repulsion between
Ab and the negatively charged phospholipid headgroups is
overcome by other interactions that allow for the same retar-
dation effect as with uncharged membranes. This is sup-
ported by monolayer experiments.
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